HONG KONG SAR –
Media OutReach Newswire – 20 February 2025 – The Chinese University of Hong Kong (CUHK) has achieved its highest-ever rankings: 44th in the Times Higher Education (THE) World University Rankings 2025 and 36th in the QS World University Rankings 2025. Through its Faculty of Medicine, CUHK demonstrates how academic excellence translates into meaningful improvements in people’s lives.
The
Faculty of Medicine (CU Medicine), a cornerstone of CUHK’s success since its establishment in 1981, has impressed the world with outstanding achievements in recent global rankings, driving innovation across its five schools and 14 departments. In Times Higher Education (THE) World University Rankings 2025 by Subject: Medical and Health, it is ranked 24th globally and 4th in Asia, being one of the youngest medical schools among the top 25 in the world. In the Quacquarelli Symonds (QS) Ranking by Subject 2024, CU Medicine ranked 1st in Hong Kong, 2nd in Asia; while in the 2024 Global Ranking of Academic Subjects (GRAS) by ShanghaiRanking, CU Medicine ranked 1st in Asia in Clinical Medicine and is the only Asian medical school among the Top 50.
Pioneering Healthcare Solutions
Professor Dennis Lo, the newly appointed CUHK’s Vice-Chancellor and President, has transformed prenatal care globally through Non-invasive Prenatal Testing (NIPT), benefitting over 10 million pregnant women annually across more than 100 countries. His innovations extend to cancer detection, where his team’s plasma-based screening for nasopharyngeal carcinoma has dramatically improved early detection rates.
Empowering Global Health Talent
Dr. Subhankar Mukhopadhyay, an Indian PhD graduate and
Hong Kong PhD Fellowship Scheme awardee, exemplifies the faculty’s success in nurturing talent. “CUHK’s interdisciplinary approach and state-of-the-art facilities created the perfect environment for innovative research,” says Dr. Mukhopadhyay, now a postdoctoral researcher at CUHK’s JC School of Public Health and Public Care.
Building a Healthier Future
CU Medicine is dedicated to enhancing global health through advancing healthcare, medical education and research. It conducts research in areas of primary concern to Asia and Hong Kong, including projects on cancers, gut microbiota, and metabolic diseases. By combining scientific excellence with a deep commitment to social responsibility, CU Medicine continues to pioneer solutions that make quality healthcare more accessible and effective for communities worldwide.
For a full list of postgraduate programmes available at CU Medicine, visit
www.gs.cuhk.edu.hk/medicine.
Hashtag: #CUHK
The issuer is solely responsible for the content of this announcement.
